Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$26.68 -0.71 (-2.59%)
At close: Sep 29, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Net Income (2013 - 2026)

Updated

Amphastar Pharmaceuticals' Net Income came in at $30.35 million for Q2 2026, down 2.2% from $31.03 million a year earlier but up 372.7% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Net Income (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Amphastar Pharmaceuticals reported Net Income of $78.55 million, down 41.7% year-over-year; for FY2025, it came in at $98.09 million, down 38.5% from FY2024.

  • Net Income carries a five-year compound annual growth rate of 145.6% (FY2020 to FY2025).
  • Going back by year, Net Income was $159.52 million in FY2024 (+16.0%), $137.55 million in FY2023 (+50.5%), $91.39 million in FY2022 (+44.4%) and $63.3 million in FY2021.
  • The five-year range for quarterly Net Income is $6.42 million (Q1 2026) to $49.22 million (Q3 2023).
  • Year-over-year, Net Income has declined for six consecutive quarters, with an average decline of 30.3% over the last eight quarters.
  • The fastest year-over-year change in Net Income over five years came in Q3 2021 (growth of 545.9%), and the weakest in Q1 2026 (a decline of 74.6%).
  • Business Quant data shows AMPH's Net Income at $6.42 million (Q1 2026), $24.43 million (Q4 2025) and $17.35 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 5.53 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 3.62 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 3.26 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 2.51 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -10.50 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -237.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.10 Bn
10 Amphastar Pharmaceuticals 1.16 Bn 23.86 Mn 93.47 Mn 30.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.35 Mn
Mar 31, 2026 6.42 Mn
Dec 31, 2025 24.43 Mn
Sep 30, 2025 17.35 Mn
Jun 30, 2025 31.03 Mn
Mar 31, 2025 25.29 Mn
Dec 31, 2024 37.96 Mn
Sep 30, 2024 40.43 Mn
Jun 30, 2024 37.95 Mn
Mar 31, 2024 43.18 Mn
Dec 31, 2023 36.17 Mn
Sep 30, 2023 49.22 Mn
Jun 30, 2023 26.12 Mn
Mar 31, 2023 26.03 Mn
Dec 31, 2022 33.91 Mn
Sep 30, 2022 15.87 Mn
Jun 30, 2022 17.35 Mn
Mar 31, 2022 24.25 Mn
Dec 31, 2021 19.76 Mn
Sep 30, 2021 30.96 Mn
API Access

Amphastar Pharmaceuticals Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=AMPH&period=max&api_key=YOUR_API_KEY